Home » Topics » BioWorld Science

BioWorld Science
RSS

Banyu discloses natural anticancer compounds

Sep. 6, 1996

Anticancer benzodiazepines from Genentech

Sep. 6, 1996

Additional patent coverage for Maxim anticancer combination

Sep. 6, 1996

alpha1-Adrenoceptor antagonist effective in suppressing prostate cancer growth

Sep. 6, 1996

Kosan receives funds for drug design

Sep. 6, 1996

Generic product from Barr Laboratories cleared by FDA

Sep. 6, 1996

Abbott evaluating clitocine analogues

Sep. 6, 1996

VZIG clinical studies progress in post-herpetic neuralgia

Sep. 6, 1996

Russian launch for GMDP

Sep. 6, 1996

Abbott describes immunosuppressants

Sep. 6, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...